On Thursday, Following Stocks were among the “Top Gainers” In U.S. Stock Exchange: Zynga (NASDAQ:ZNGA), Johnson & Johnson (NYSE:JNJ), Silver Wheaton (NYSE:SL), Galena Biopharma (NASDAQ:GALE)
Zynga Inc (NASDAQ:ZNGA), rose 1.15%, and closed at $2.65. The stock has the beta value of 2.14, and its volatility for the week is 4.38%, while for the month it is 3.66%. The company has the market capitalization of $2.39 billion. The company holds the book value per share of 2.13, whereas cash per share is 1.01. Price to book ratio remained 1.24, while price to sale ratio is 3.50. Analysts mean recommendation for the stock is said to be 2.90 (where 1=Buy, 5=sale).
Zynga Inc (ZNGA) develops, markets, and operates online social games as live services played on the Internet, social networking sites, and mobile platforms in the United States and globally.
Johnson & Johnson (NYSE:JNJ) will host a symposium call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 14th, to review first-quarter results. Dominic Caruso, Vice President, Finance and Chief Financial Officer and Louise Mehrotra, Vice President, Investor
Johnson & Johnson (NYSE:JNJ) raised 0.23%, and closed at $101.69. The stock has price to sale ratio of 3.80, however, price to book ratio is 4.07. With recent incline, the year-to-date (YTD) performance reflected a -3.48% decline below last year. During the past month the stock gain 0.98%, bringing three-month performance to -3.66% and six-month performance to -5.83%. The mean recommendation of analysts for this stock is 2.50 (where 1=Buy, 5=Sale).
Johnson & Johnson (JNJ) along with its subsidiaries researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Silver Wheaton Corp. (USA) (NYSE: SLW) reveal that its Board of Directors has uncovered its first quarterly cash dividend payment for 2015 of US$0.05 for each ordinary share. The first quarterly cash dividend of US$0.05 will be paid to holders of record of Silver Wheaton ordinary shares as of the close of business on March 31, 2015, and will be distributed on or about April 14, 2015.
Silver Wheaton Corp. (USA) (NYSE: SLW) inclined -2.16%, and closed at $19.42. The company has the market capitalization of $7.68 billion. The beta value of the stock is 0.75. On the other hand the stock’s volatility for the week is 3.74%, and for the month is 2.96%. The stock’s price to book ratio is 1.93, however price to sale ratio is -11.05. Analyst’s mean recommendation regarding this stock is 2.00. (Where 1=Buy, 5=Sale).
Silver Wheaton Corp. (USA) (SLW) works as a precious metals streaming corporation worldwide. The corporation has 20 long-term purchase contracts and 1 early deposit long-term purchase contract associated with silver and/or gold regarding24 different mining assets.
Galena Biopharma Inc (NASDAQ:GALE) a biopharmaceutical corporation developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, recently declared the closing of its formerly declared underwritten public offering of 24,358,974 shares of ordinary stock, and warrants to purchase an aggregate of 12,179,487 shares of ordinary stock at an exercise price of $2.08 per share. The underwriters also exercised their over-allotment option to purchase warrants to purchase an aggregate of 1,826,923 shares of ordinary stock. The warrants are right away exercisable and expire on the fifth anniversary of the date of issuance. The shares of ordinary stock and warrants are right away separable and will be issued separately.
Galena Biopharma Inc (NASDAQ:GALE)’s shares picked up 5.67%, and closed at $1.49. The stock volatility for the week is 7.06%, while for the month remained 6.89%. The company holds consensus target price of $5.14.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.31 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 63.50% and Annual EPS growth for the past 5 years is considered as 24.20%.
The mean recommendation of analysts for this stock is 2.40. (Where 1=Buy, 5=Sale).
Galena Biopharma Inc (GALE) a biopharmaceutical corporation focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care. Its commercial product comprises Abstral, a sublingual tablet, which is used as treatment option for breakthrough cancer pain in patients.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
